 JERSEY, Channel Islands, Nov. 30, 2020 GLOBE NEWSWIRE -- Quotient Limited NASDAQ:QTNT, a commercial-stage diagnostics company the Company, today reported preliminary EU field trial performance data for its MosaiQ Expanded Immunohematology IH Microarray. The data suggest that tests performed with Quotients Microarray are highly accurate. 